• Markets
  • icon
  • Companies
RSH · ASX

Respiri Limited (ASX:RSH)

AU$0.029

 -0.001 (-3.333%)
ASX:Live
24/05/2024 11:08:06 AM
HALO Ords GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

RSH Overview

RSH Health Scores

Short Term

Mean Revision

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Strong

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About RSH

Website

N/A

Telephone

Address

Description

Respiri Ltd. engages in research, development, and commercialization of medical devices and the production of mobile health applications for management of asthma and related chronic respiratory diseases. Its proprietary apps, software, and devices will help people monitor the symptoms of their conditions, increase their awareness of risk of attack, adhere to their medication plans, improve outcomes, and reduce healthcare expenditures. The firm operates through the Australia and Israel segments. The Australia segment includes research, development, and commercialization of medical devices, and the production of mobile health applications in Australia. The Israel segment refers to the research, development and, commercialization of medical devices, and the production of mobile health applications in Israel. The company was founded by Noam Gavriely in 1987 and is headquartered in Melbourne, Australia.

RSH Price Chart

Key Stats

Market Cap

AU$31.80M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.02 - 0.05

Trade Value (12mth)

AU$4,274.00

1 week

-18.92%

1 month

-9.09%

YTD

3.45%

1 year

-23.08%

All time high

6.574739933013916

Key Fundamentals

EPS 3 yr Growth

-43.300%

EBITDA Margin

%

Operating Cashflow

-$4m

Free Cash Flow Return

-227.30%

ROIC

-292.30%

Interest Coverage

-418.30

Quick Ratio

0.80

Other Data

Shares on Issue (Fully Dilluted)

906m

HALO Sector

Next Company Report Date

28-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

RSH Announcements

Latest Announcements

Date Announcements

09 May 24

May 2024 Investor Presentation

×

May 2024 Investor Presentation

03 May 24

Change of Director's Interest Notice - MM

×

Change of Director's Interest Notice - MM

03 May 24

Change of Director's Interest Notice - NS

×

Change of Director's Interest Notice - NS

02 May 24

Respiri Market Update Presentation

×

Respiri Market Update Presentation

01 May 24

Notification regarding unquoted securities - RSH

×

Notification regarding unquoted securities - RSH

30 April 24

Respiri Raises $1.6 million through Additional Placement

×

Respiri Raises $1.6 million through Additional Placement

30 April 24

Proposed issue of securities - RSH

×

Proposed issue of securities - RSH

30 April 24

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

29 April 24

RSH contracts first Hawaii independent physician association

×

RSH contracts first Hawaii independent physician association

18 April 24

Results of Meeting

×

Results of Meeting

19 March 24

Notice of General Meeting/Proxy Form

×

Notice of General Meeting/Proxy Form

19 March 24

2024 GM - Letter to Shareholders & Proxy Form

×

2024 GM - Letter to Shareholders & Proxy Form

08 March 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

29 February 24

Appendix 4D and Half Year Financial Report

×

Appendix 4D and Half Year Financial Report

31 January 24

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

29 January 24

Appointment of Company Secretaries

×

Appointment of Company Secretaries

25 January 24

EIQ: EIQ Licenses Software to Respiri - Remote Patient Mon.

×

EIQ: EIQ Licenses Software to Respiri - Remote Patient Mon.

25 January 24

Cardiovascular AI platform integrated into RPM program

×

Cardiovascular AI platform integrated into RPM program

19 December 23

Application for quotation of securities - RSH

×

Application for quotation of securities - RSH

19 December 23

s708A cleansing statement

×

s708A cleansing statement

15 December 23

Application for quotation of securities - RSH

×

Application for quotation of securities - RSH

14 December 23

$6.5m raised for US expansion, $20m commitment secured

×

$6.5m raised for US expansion, $20m commitment secured

14 December 23

Reinstatement to Official Quotation

×

Reinstatement to Official Quotation

14 December 23

Disclosure Document - Replacement Prospectus

×

Disclosure Document - Replacement Prospectus

14 December 23

Director Appointment - Dr Tom Takubo

×

Director Appointment - Dr Tom Takubo

RSH Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.02 -0.01 -0.01 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.02 -0.01 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock -24.4 42.4 20.9 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.01 -0.01 -0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.01 -0.01 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock -73.0 20.9 22.2 Lock Lock Lock
     Yield % Lock Lock Lock Lock -15.8 -21.2 -14.7 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.01 0.00 0.00 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.01 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 173.6 -62.3 -75.2 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 699 729 806 Lock Lock Lock
Basic m Lock Lock Lock Lock 699 729 806 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A -6.1 -72.2 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 10 5 4 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -2 -2 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock -21,670.2 16.1 -29.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock -836.7 -747.7 -3,468.3 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 937 848 3,568 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -12 -7 -6 Lock Lock Lock
     Growth % Lock Lock Lock Lock -27.8 41.5 11.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -4,473.7 -2,786.0 -8,895.9 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -12 -7 -6 Lock Lock Lock
     Growth % Lock Lock Lock Lock -28.5 41.2 11.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -4,503.2 -2,818.3 -9,005.5 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -12 -7 -6 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -1 0 -1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -11 -7 -6 Lock Lock Lock
     Growth % Lock Lock Lock Lock -52.1 40.0 12.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -4,087.9 -2,611.2 -8,188.1 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -7 -8 -4 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 12 2 3 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -7 -8 -5 Lock Lock Lock
     Growth % Lock Lock Lock Lock -57.3 -14.7 46.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -27.4 -33.4 -64.0 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 8 1 0 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 9 4 3 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -8 -1 0 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 2 1 2 Lock Lock Lock
Equity $m Lock Lock Lock Lock 8 3 1 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 8 3 1 Lock Lock Lock
     Growth % Lock Lock Lock Lock 191.3 -60.6 -68.6 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -121.2 -157.5 -181.5 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -145.8 -220.2 -698.4 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -219.1 -132.5 -313.3 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -215.1 -124.4 -292.3 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -143.0 -159.2 -227.3 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock N/A N/A -418.3 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.6 0.2 -0.0 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -103.4 -38.1 0.4 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 6.1 3.4 1.3 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 5.7 1.2 0.8 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 89.1 29.5 4.9 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -500.4 -707.9 -200.6 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 3.7 2.7 1.4 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 6.0 1.3 1.3 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.1 0.1 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 400.1 206.7 2,139.0 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.1 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.1 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -4,453.2 -2,807.0 -8,968.9 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -132.1 -169.3 -198.8 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -121.2 -157.5 -181.5 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.2 1.4 3.8 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -145.8 -220.2 -698.4 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -145.8 -220.2 -698.4 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 61.0 270.6 281.5 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 97.4 134.0 252.4 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 158.5 404.6 533.9 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 129.1 68.7 338.1 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 29.4 335.9 195.8 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

RSH Shortsell

Frequently Asked Questions

The current share price of Respiri Limited (RSH:ASX) is AU$0.029.
The 52-week high share price for Respiri Limited (RSH:ASX) is AU$0.05.
The 52-week low share price for Respiri Limited (RSH:ASX)? is AU$0.02.
Respiri Limited (RSH:ASX) does not pay a dividend.
Respiri Limited (RSH:ASX) does not pay a dividend.
Respiri Limited (RSH:ASX) has a franking level of 0.0%.
Respiri Limited (RSH:ASX) is classified in the Healthcare.
The current P/E ratio for Respiri Limited (RSH:ASX) is .